3B Future Health Fund

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.

Roca Therapeutics focuses on the research and development of small medicines to treat severe, life-threatening diseases.

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.